Nonalcoholic fatty liver disease risk and histologic severity are associated with genetic polymorphisms in children

Nidhi P. Goyal, Sara B. Rosenthal, Chanod Nasamran, Cynthia A. Behling, Jorge E. Angeles, Mark H. Fishbein, Kathryn E. Harlow, Ajay K. Jain, Jean P. Molleston, Kimberly P. Newton, Patricia Ugalde‐Nicalo, Stavra A. Xanthankos, Katherine Yates, Nicholas J. Schork, Kathleen M. Fisch, Jeffrey B. Schwimmer, for the NASH Clinical Research Network – 12 May 2022

Mid‐upper arm circumference is associated with liver steatosis and fibrosis in patients with metabolic‐associated fatty liver disease: A population based observational study

Xiaoxiao Wang, Xiaohe Li, Rui Jin, Jia Yang, Rui Huang, Lai Wei, Feng Liu, Huiying Rao – 12 May 2022 – Metabolic‐associated fatty liver disease (MAFLD) is a series of liver diseases based on liver steatosis and metabolic disorders. Steatosis, as the core factor in MAFLD diagnosis, and fibrosis, as the major determinant of adverse outcomes of MAFLD, need to be assessed simply and accurately. In this study, we explored the significance of mid‐upper arm circumference (MUAC) in evaluating liver steatosis and fibrosis in patients with MAFLD.

Metabolic reprogramming of the intestinal microbiome with functional bile acid changes underlie the development of NAFLD

Ekaterina Smirnova, Mark D. Muthiah, Nicole Narayan, Mohamad S. Siddiqui, Puneet Puri, Velimir A. Luketic, Melissa J. Contos, Michael Idowu, Jen‐Chieh Chuang, Andrew N. Billin, Ryan S. Huss, Robert P. Myers, Sherry Boyett, Mulugeta Seneshaw, Hae‐Ki Min, Faridodin Mirshahi, Arun J. Sanyal – 12 May 2022

Online Learning Committee

The Online Learning Committee develops and implements AASLD online educational activities for healthcare providers with the goals of increasing scientific knowledge and addressing professional practice gaps by improving competence and performance, thereby improving the care of patients with liver disease.

Subscribe to